Pharmaceutical industry in the United Kingdom

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

UK Pharmaceutical employment of 73,000 in 2017 compares to 114,000 as of 2015 in Germany, 92,000 as of 2014 in France and 723,000 in the European Union as a whole. In the United States 281,440 people worked in the pharmaceutical industry as of 2016.

By the early 2020s, the scale of the UK pharmaceutical industry had increased substantially. According to the Association of the British Pharmaceutical Industry (ABPI), the sector directly employed around 126,000 people, contributed approximately £17.6 billion in direct gross value added (GVA), and generated exports worth around £26.1 billion in 2023.

The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, Hoffmann–La Roche and Eisai. One in five of the world's biggest-selling prescription drugs were developed in the UK.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.